Comparison of -specific Antibody Cut-offs for the Diagnosis of Aspergillosis

Background: diseases are frequently encountered in patients who are immunocompromised. Without a prompt diagnosis, the clinical consequences may be lethal. -specific antibodies have been widely used to facilitate the diagnosis of diseases. To date, universally standardized cut-off values have not been established. This study aimed to investigate the cut-off values of -specific antibodies and perform a narrative review to depict the geographic differences in the Taiwanese population.

Methods: We analyzed enrolled 118 healthy controls, 29 patients with invasive aspergillosis (IA), chronic pulmonary aspergillosis (CPA), and allergic bronchopulmonary aspergillosis (ABPA) and 99 with disease control, who were tested for and -specific IgG and IgE using ImmunoCAP. 99 participants not fulfilling the diagnosis of IA, CPA, and ABPA were enrolled in the disease control group. The duration of retrieval of medical records from June 2018 to September 2021. Optimal cut-offs and association were determined using receiver operating characteristic curve (ROC) analysis.

Results: We found that patients with CPA had the highest -specific IgG levels while patients with ABPA had the highest -specific IgE, and -specific IgG and IgE levels. In patients with CPA and ABPA, the optimal cut-offs of -specific IgG and -specific IgG levels were 41.6, 40.8, 38.1, and 69.9 mgA/l, respectively. Geographic differences in the cut-off values of -specific IgG were also noted. Specifically, the levels were different in eco-climatic zones.

Conclusion: We identified the optimal cut-offs of -specific antibodies to facilitate a precise diagnosis of aspergillosis. The observed geographic differences of the antibody levels suggest that an eco-climatic-specific reference is needed to facilitate a prompt and accurate diagnosis of aspergillosis.